A stronger U.S. dollar and weak medical-device sales pressured Johnson & Johnsonâ€™s first-quarter results and full-year outlook, while the health-care giant leaned on its growing pharmaceutical unit to partially offset declines in other segments.

J&J said Tuesday its first-quarter profit dropped 8.6% while sales declined 4.1% from a year earlier. The New Brunswick, N.J., company, which derives half of its revenue from outside...